IRIX insider buying & filings

← All candidates

IRIXIRIDEX CORP

NasdaqCM · Healthcare · $10.94M

$0.6070

-3.65% today

One insider bought $5.0K in five days.
Led by Dizon Romeo R, chief financial officer.

Last Form 4 Sep 14 · scanned 4m ago

Price · 1Y · daily● 41 buys◆ 4 8-K

▸ hover a marker for the filing · drag to zoom · 4 moves explained

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

▸ Included with Pro →

Market cap

$10.94M

Float

5.2M

30% public

Short % float

Pro

Price / profit

—

not yet profitable

Price / future profit

—

Price / sales

0.2

The buyers

▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions

Director

Moore William M

Bought $27.2K on Nov 14 — 28,157 sh @ $0.9676, held direct, 12% of their stake.

1 of 2 positions beat the S&P

median +12.4% vs S&P +13.3% same spans · 10 buy-days

Chief Financial Officer

Dizon Romeo R

Bought $13.0K on Nov 14 — 14,769 sh @ $0.8800, held direct, 19% of their stake.

1 of 2 positions beat the S&P

median +12.0% vs S&P +16.0% same spans · 57 buy-days · 1 positions still open

President and CEO

Mercer Patrick

Bought $240.00 on Jun 13 — 250 sh @ $0.9600, held direct, 0.1% of their stake.

0 of 1 position beat the S&P

median -1.1% vs S&P +14.6% same spans

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Sep 14BUYDizon Romeo RChief Financial Officer+1.3%direct2,354 @ $0.6500$1.5K

Sep 10BUYDizon Romeo RChief Financial Officer+2.9%direct5,100 @ $0.6800$3.5K

Aug 24BUYDizon Romeo RChief Financial Officer+3.2%direct5,368 @ $0.7499$4.0K

Aug 24BUYDizon Romeo RChief Financial Officer+0.8%direct1,300 @ $0.7488$973.44

Jun 16TAXDizon Romeo RChief Financial Officerdirect2,691 @ $1.12$3.0K

104 more transactions on Pro →

Context

Wall St

$2.75 avg target

+353.0% vs today · 1 analyst · consensus Strong Buy

▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice

Earnings · EPS vs forecast

2 of 3 quarters beat

Q1 '26−$0.03 act+$0.04

Q4 '25$0.00 act+$0.02

Q3 '25−$0.09 act

Coverage

IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product GrowthZacks · 05-25 IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...GuruFocus.com · 05-20 IRIDEX Corporation Q1 2026 Earnings Call SummaryMoby · 05-20 Iridex's Q4 Loss Narrows Year Over Year on Retina Sales GrowthZacks · 04-01

The file stays open

109 filings on record.
The next one will be too.

All candidates

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice

Moore William M

Dizon Romeo R

Mercer Patrick

109 filings on record.The next one will be too.

109 filings on record.
The next one will be too.